Vendor, Willowbrook, IL
Dupage Medical Technology Inc.
UEI PBQ3ANGJVJ15, CAGE 7BUT7
1 award and $0 obligated between July 1, 2024 and July 1, 2024, 100% under full and open competition, against 23.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Professional, Scientific, and Technical ServicesNAICS 541712 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSN268201700002CDefinitive Contract, July 1, 2024, Full and Open Competition, 23 offers | National Institutes of Health NhlbiNational Institutes of Health | Developing an Inhibitor of Integrin Outside-In Signaling as a New Generation of Anti-Thrombotic Drug - Vita 2NAICS 541712, PSC AN11 | $0 |
- Places of performance
- Illinois
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 1 across 1 awards